跳至主要内容
临床试验/EUCTR2015-002533-22-DK
EUCTR2015-002533-22-DK进行中(未招募)1 期

Palliation of dyspnea with morphine in patients with interstitial lung disease - MORPHILD

Aarhus University Hospital0 个研究点目标入组 36 人开始时间: 2015年6月12日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • A diagnosis of interstitial lung disease (IPF, NSIP, RA-ILS, Scl-ILS, MCTD-ILS, asbestosis, drug induced ILD, un classified ILD)
  • Dyspnea Medial Research Councils (MRC) dyspnea score = 3
  • Informed written consent
  • Age = 18 years
  • For fertile women: negative HCG before inclusion
  • For fertile and sexualle active persons: Secure birth control during the study period and the day after
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range 18
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 18

排除标准

  • Treatment with morpine or morphne analogues
  • Allergy towards morphine

研究者

发起方
Aarhus University Hospital

相似试验